Assistant Professor of Surgery
Division of Trauma, Critical Care and Burn

DEifermanDirector of Special Operations - Quality and Patient Safety


Dr. Eiferman is board certified in General Surgery and Surgical Critical Care. In conjunction with Dr. Skoracki, the Lymphedema Center for Excellence hopes to continue to be at the forefront of finding novel treatments and a possible cure for lymphedema.

  • BA: Northwestern University, Evanston, IL, Molecular and Cell Biology
  • MD: University of Kentucky, Lexington KY
  • Residency: University/Stroger Hospital of Cook County, Chicago, IL, General Surgery
  • Fellowship: Ohio State University, Columbus, OH, Surgical Critical Care
  • MBA: Ohio State University, Columbus, OH

Research Interests
  • Lymphedema
  • Abdominal Wall Reconstruction
  • Traumatic Brain Injury

View PubMed

View Clinical Bio

Current Funding

  • September 2017  Godbout J (Primary Investigator).  Acute and Long-Term Benefits of Methylene Blue Intervention After TBI on Neuroinflammation, Glial Dysfunction, and Neuropsychiatric Complications. NIH R01, National Institute of Neurological Disorders and Stroke.  Co-Investigator

  • March 2016 Godbout J, Sheridan J, Eiferman D. “The Elimination of Microglia by a CSF-1R Antagonist to Prevent or Reverse TBI-induced Chronic Inflammation Associated with Microglia Priming and Reactivity.” Discovery Theme Chronic Brain Injury Pilot Program, The Ohio State University. Co-Investigator.

  • Jul 2014 Eiferman D, Godbout J, "Attenuation of Neuroinflammation by Methylene Blue Intervention in a Mouse Model of Traumatic Brain Injury.   American Surgical Association.  Principal Investigator.

  • Oct 2013 Godbout J, Eiferman D, "Methylene Blue Intervention to Attenuate Traumatic Brain Injury-Associated Microglial Priming and Reactivity" Ohio State University College of Medicine, Co-Investigator.